Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (8): 808-812.doi: 10.3969/j.issn.1000-6621.2021.08.010
• Original Articles • Previous Articles Next Articles
WANG Li, XIONG Kun-long, ZHU Chang-tai(), FAN Lin(
)
Received:
2021-04-22
Online:
2021-08-10
Published:
2021-07-30
Contact:
WANG Li,ZHU Chang-tai,FAN Lin
E-mail:zct101@163.com;fanlinsj@163.com
WANG Li, XIONG Kun-long, ZHU Chang-tai, FAN Lin. T lymphocyte exhaustion on the expression of immune effect in patients with multidrug-resistant pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 808-812. doi: 10.3969/j.issn.1000-6621.2021.08.010
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.08.010
抑制性受体 | MDR-PTB组 | DS-PTB组 | HD组 | Z值 | P值a | Z值 | P值b | Z值 | P值c |
---|---|---|---|---|---|---|---|---|---|
CD4-PD-1 | 24.50(21.58,26.00) | 14.50(11.90,20.00) | 13.10(11.80,17.80) | -4.009 | <0.01 | -4.159 | <0.01 | -0.410 | 0.535 |
CD8-PD-1 | 19.95(16.10,21.65) | 13.20(8.61,18.23) | 12.55(9.61,18.18) | -3.027 | 0.001 | -3.284 | 0.001 | -0.165 | 0.874 |
CD4-Tim-3 | 3.75(3.20,4.68) | 1.12(0.71,3.36) | 0.67(0.46,2.41) | -3.565 | 0.001 | -3.967 | <0.01 | -1.151 | 0.255 |
CD8-Tim-3 | 12.65(10.65,14.10) | 3.59(2.10,7.52) | 3.78(2.35,6.55) | -5.568 | <0.01 | -3.261 | 0.001 | -0.084 | 0.941 |
CD4-Lag-3 | 2.27(0.66,4.43) | 1.11(0.65,1.91) | 1.11(0.81,1.55) | -1.076 | 0.293 | -1.304 | 0.196 | -0.020 | 0.988 |
CD8-Lag-3 | 20.90(16.00,34.80) | 25.05(18.05,32.35) | 24.15(16.75,29.68) | -0.492 | 0.446 | 0.310 | 0.883 | -0.583 | 0.340 |
免疫效应因子 | MDR-PTB组 | DS-PTB组 | HD组 | Z值 | P值a | Z值 | P值b | Z值 | P值c |
---|---|---|---|---|---|---|---|---|---|
CD4-IL-2 | 1.30(0.73,2.71) | 1.51(0.83,2.10) | 0.67(0.44,1.10) | -0.460 | 0.654 | -2.670 | 0.005 | -3.788 | <0.01 |
CD8-IL-2 | 2.27(1.03,3.11) | 2.12(1.55,3.04) | 0.59(0.39,0.91) | -0.932 | 0.358 | -3.917 | <0.01 | -5.285 | <0.01 |
CD4-IFN-γ | 0.45(0.30,1.65) | 0.92(0.59,2.02) | 0.65(0.38,0.82) | -1.499 | 0.136 | -0.349 | 0.736 | -2.337 | 0.019 |
CD8-IFN-γ | 1.16(0.53,2.03) | 1.80(0.97,3.04) | 0.69(0.35,0.91) | -1.670 | 0.096 | -1.988 | 0.047 | -4.455 | <0.01 |
CD4-TNF-α | 0.41(0.28,0.82) | 0.83(0.67,1.22) | 0.44(0.28,0.71) | -2.919 | 0.003 | -0.179 | 0.862 | -3.903 | <0.01 |
CD8-TNF-α | 1.23(0.57,1.44) | 0.84(0.42,1.22) | 0.61(0.40,1.00) | -1.203 | 0.231 | -1.444 | 0.153 | -0.673 | 0.508 |
[1] | 吴碧彤, 谭守勇, 蔡杏珊, 等. 耐药结核性胸膜炎胸液生化及临床特点. 广东医学, 2017, 38(17):2617-2620. doi: 10.3969/j.issn.1001-9448.2017.17.009. |
[2] | 蒋龄周. 贞芪扶正颗粒联合抗结核药治疗肺结核临床疗效及对T淋巴细胞亚群的影响. 中医药信息, 2017, 34(5):104-107. doi: 10.3969/j.issn.1002-2406.2017.05.030. |
[3] |
Brighenti S, Andersson J. Local immune responses in human tuberculosis: learning from the site of infection. J Infect Dis, 2012, 205Suppl 2:S316-324. doi: 10.1093/infdis/jis043.
doi: 10.1093/infdis/jis043 URL |
[4] |
Wherry EJ. T cell exhaustion. Nature Immunology, 2011, 12(6):492-499. doi: 10.1038/ni.2035.
URL pmid: 21739672 |
[5] |
Day CL, Abrahams DA, Lerumo L, et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol, 2011, 187(5):2222-2232. doi: 10.4049/jimmunol.1101122.
doi: 10.4049/jimmunol.1101122 URL |
[6] |
Lee JS, Song CH, Kim CH, et al. Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol, 2002, 128(3):516-524. doi: 10.1046/j.1365-2249.2002.01858.x.
URL pmid: 12067307 |
[7] |
Geffner L, Yokobori N, Basile J, et al. Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun, 2009, 77(11):5025-5034. doi: 10.1128/IAI.00224-09.
doi: 10.1128/IAI.00224-09 URL pmid: 19720756 |
[8] | Churina EG, Urazova OI, Novitskiy VV. The role of foxp3-expressing regulatory T cells and T helpers in immunopathogenesis of multidrug resistant pulmonary tuberculosis. Tuberc Res Treat, 2012, 2012:931291. doi: 10.1155/2012/931291. |
[9] |
Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol, 2015, 36(4):265-276. doi: 10.1016/j.it.2015.02.008.
doi: 10.1016/j.it.2015.02.008 URL |
[10] |
Khan N, Vidyarthi A, Amir M, et al. T-cell exhaustion in tuberculosis: pitfalls and prospects. Crit Rev Microbiol, 2017, 43(2):133-141. doi: 10.1080/1040841X.2016.1185603.
doi: 10.1080/1040841X.2016.1185603 URL |
[11] |
Day CL, Moshi ND, Abrahams DA, et al. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment. PLoS One, 2014, 9(4):e94949. doi: 10.1371/journal.pone.0094949.
doi: 10.1371/journal.pone.0094949 URL |
[12] |
Sakai S, Kawamura I, Okazaki T, et al. PD-1-PD-L1 pathway impairs Th1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin. Int Immunol, 2010, 22(12):915-925. doi: 10.1093/intimm/dxq446.
doi: 10.1093/intimm/dxq446 URL |
[13] |
Jayaraman P, Jacques MK, Zhu C, et al. TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection. PLoS Pathog, 2016, 12(3):e1005490. doi: 10.1371/journal.ppat.1005490.
doi: 10.1371/journal.ppat.1005490 URL |
[14] | 任军, 黄红艳. 靶向免疫检查点的肿瘤免疫治疗现状与趋势. 中国肿瘤临床, 2014, 41(7):415-419. doi: 10.3969/j.issn.1000-8179.20140359. |
[15] |
Otano I, Escors D, Schurich A, et al. Molecular Recalibration of PD-1+Antigen- Specific T Cells from Blood and Liver. Mol Ther, 2018, 26(11):2553-2566. doi: 10.1016/j.ymthe.2018.08.013.
doi: 10.1016/j.ymthe.2018.08.013 URL |
[16] |
Nebbia G, Peppa D, Schurich A, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One, 2012, 7(10):e47648. doi: 10.1371/journal.pone.0047648.
doi: 10.1371/journal.pone.0047648 URL |
[17] | 陈少华, 查显丰, 李扬秋. TIM-3、LAG-3和BTLA介导的血液肿瘤免疫耐受及其逆转研究. 中国实验血液学杂志, 2016, 24(5):1594-1597. doi: 10.7534/j.issn.1009-2137.2016.05.056. |
[18] |
Torphy RJ, Schulick RD, Zhu Y. Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy. Int J Mol Sci, 2017, 18(12):2642. doi: 10.3390/ijms18122642.
doi: 10.3390/ijms18122642 URL |
[19] |
Tan Q, Xie WP, Min R, et al. Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis, 2012, 31(6):1233-1242. doi: 10.1007/s10096-011-1434-4.
doi: 10.1007/s10096-011-1434-4 URL |
[20] |
Turner J, Frank AA, Brooks JV, et al. Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology. Immunology, 2001, 102(2):248-253. doi: 10.1046/j.1365-2567.2001.01161.x.
URL pmid: 11260331 |
[21] |
Crawford A, Angelosanto J, Kao C, et al. Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection. Immunity, 2014, 40(2):289-302. doi: 10.1016/j.immuni.2014.01.005.
doi: 10.1016/j.immuni.2014.01.005 URL pmid: 24530057 |
[22] | Fan L, Xiao H, Mai G, et al. Impaired M.tuberculosis Antigen-Specific IFN-gamma Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary Tuberculosis. PLoS One, 2015, 10(5):e127087. doi: 10.1371/journal.pone.0127087. |
[23] |
Takashima T, Ueta C, Tsuyuguchi I, et al. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect Immun, 1990, 58(10):3286-3292. doi: 10.1128/IAI.58.10.3286-3292.1990.
URL pmid: 2205576 |
[1] | Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan. Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180. |
[2] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
[3] | Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei. Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062. |
[4] | Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei. Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097. |
[5] | Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong. Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896. |
[6] | Jia Hongyan, Fan Jun, Sun Qi, Song Ruixue, Du Boping, Dong Jing, Wang Yingchao, Xing Aiying, Zhu Chuanzhi, Li Zihui, Pan Liping. Comparison of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold In-Tube assay in auxiliary diagnosis of osteoarticular tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 648-653. |
[7] | Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin. Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423. |
[8] | Li Ting, Liu Shuang, Wang Danxia, Lu Jia, Cheng Qianqian, Chen Chuang, He Jin’ge, Zhang Linglin, Xia Yong, Li Jing, Zhang Shu, Gao Wenfeng, Xia Lan. Evaluation of health economics of implementation of tuberculosis prevention and control program in Sichuan Province from 2011 to 2020 [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 333-339. |
[9] | Li Xuelian, Jing Wei, Wang Qingfeng, Chu Naihui, Nie Wenjuan. An all-oral shortened regimen containing new drugs to treat MDR/rifampicin-resistant tuberculosis: three case reports and literature review [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1327-1334. |
[10] | Hu Qiang, Jin Linyuan, Zhou Xiaohui, Zhang Qianrong, Deng Yuhang, Tang Xianpeng, Zhou Haiyi, Zhang Min. The value of ultrasound examination in the diagnosis and treatment evaluation of chest tuberculosis in children [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1350-1355. |
[11] | Song Hongge, Liu Weigao. Evaluation of the curative effect of total hip joint type space holder in the treatment of middle and advanced hip joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(8): 781-785. |
[12] | Yue Yongning, Fan Dapeng, Shang Xuechai, Li Hao, Li Huanyu, Zhou Jinyang, Cai Long. Evaluation of the effect of BS-400 Automatic Mycobacterium Liquid Culture System on Mycobacterium culture [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 483-487. |
[13] | Mao Hongkai, Zhang Yan, Liang Zhichao, Xia Wenjun, Bao Liangliang, Mayisha·Daken , Wang Xiaomin, Cao Mingqin. Evaluation of implementation effect of pulmonary tuberculosis prevention and control strategy in southern Xinjiang based on synthetic control method [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 383-390. |
[14] | Wang Honghong, Guo Shaochen, Zhou Wenqiang, Liu Zhongquan, Zhu Hui, Lu Yu. Influence of linezolid blood concentration on hematological toxicity in drug-resistant tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 165-171. |
[15] | Shi Dawei, Chen Xianglin, Dong Wenzhu, Wen Shuan, Zhang Tingting, Wang Yufeng, Huang Hairong, Xu Sihong. Development of national reference panel for Mycobacterium tuberculosis antigen detection kits [J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1141-1146. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||